Esperion Therapeutics Inc. (NASDAQ: ESPR): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that RFK, Esperion Therapeutics Announce 2024 Promotional Schedule.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

ESPR belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $2.60 and fluctuated between $2.7500 as its day high and $2.5600 as its day low. The current market capitalization of Esperion Therapeutics Inc. is $443.09M. A total of 3.53 million shares were traded on the day, compared to an average of 0.58 shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, ESPR has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 17 BUYs and 14 SELLs from insiders. Insiders purchased 286,561 shares during that period but sold 30,004.

In the most recent transaction, Warren Eric sold 742 shares of ESPR for 1.25 per share on Sep 20. After the transaction, the Chief Commercial Officer now owns 68,318 company shares. In a previous transaction on Aug 18, Warren Eric sold 243 shares at 1.41 per share. ESPR shares that Chief Commercial Officer owns now total 69,060.

Among the insiders who sold shares, Warren Eric disposed of 106 shares on Jul 19 at a per-share price of $1.58. This resulted in the Chief Commercial Officer holding 69,303 shares of ESPR after the transaction. In another insider transaction, Warren Eric sold 603 shares at $1.48 per share on Jun 21. Company shares held by the Chief Commercial Officer now total 69,409.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for ESPR in the last 3 months, the mean price target is $8.54 with high estimates of $22.00 and low estimates of $2.80. In terms of 52-week highs and lows, ESPR has a high of $6.74 and a low of $0.70.

As of this writing, ESPR has an earnings estimate of -$0.48 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.35 per share and a lower estimate of -$0.62. The company reported an EPS of -$0.46 in the last quarter, which was 24.60% higher than expectations of -$0.61.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ESPR’s latest balance sheet shows that the firm has $259.33M in Cash & Short Term Investments as of fiscal 2021. There were $260.20M in debt and $73.35M in liabilities at the time. Its Book Value Per Share was -$3.66, while its Total Shareholder’s Equity was -$196.94M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ESPR is Buy with a score of 4.13.

Most Popular

Related Posts